MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox

Documenti analoghi

• A prospective MRI study of left ventricular iron and function in non-trasfusion-dependent thalassemia intermedia patients treated with desferrioxamine
  di: Meloni, Antonella, et al.
  Pubblicazione: (2015)
• Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging
  di: Pepe, Alessia, et al.
  Pubblicazione: (2011)
• Deferiprone or deferasirox for cardiac siderosis in β thalassemia major (reply)
  di: Pepe, Alessia, et al.
  Pubblicazione: (2011)
• A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
  di: Pepe, Alessia, et al.
  Pubblicazione: (2011)
• Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
  di: Pepe, Alessia, et al.
  Pubblicazione: (2011)